BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10602169)

  • 1. Donor cell leukemia: report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature.
    Cooley LD; Sears DA; Udden MM; Harrison WR; Baker KR
    Am J Hematol; 2000 Jan; 63(1):46-53. PubMed ID: 10602169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphoblastic leukemia: case report and review of the literature.
    Reichard KK; Zhang QY; Sanchez L; Hozier J; Viswanatha D; Foucar K
    Am J Hematol; 2006 Mar; 81(3):178-85. PubMed ID: 16493618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation.
    Glasser L; Meloni-Ehrig A; Greaves W; Demel KC; Butera J
    Transfusion; 2009 Mar; 49(3):555-62. PubMed ID: 19040490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor cell derived acute myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T-cell lymphoma.
    Matsunaga T; Murase K; Yoshida M; Fujimi A; Iyama S; Kuribayashi K; Sato T; Kogawa K; Hirayama Y; Sakamaki S; Kohda K; Niitsu Y
    Am J Hematol; 2005 Aug; 79(4):294-8. PubMed ID: 16044441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor cell-derived leukemia after cord blood transplantation and a review of the literature: differences between cord blood and BM as the transplant source.
    Shiozaki H; Yoshinaga K; Kondo T; Imai Y; Shiseki M; Mori N; Teramura M; Motoji T
    Bone Marrow Transplant; 2014 Jan; 49(1):102-9. PubMed ID: 24013690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor leukemia following allogeneic bone marrow transplantation.
    Mc Cann SR; Lawler M; Gardiner N; O'Riordan J; Humphries P; De Arce M
    Leukemia; 1994 Apr; 8 Suppl 1():S133-5. PubMed ID: 8152280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myeloid leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
    Gopcsa L; Barta A; Banyai A; Konya M; Pajor L; Földi J; Paloczi K
    Bone Marrow Transplant; 2002 Mar; 29(5):449-52. PubMed ID: 11919736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonmyeloablative allogeneic bone marrow transplantation for orbital granulocytic sarcoma associated with t(8;21)(q22;q22) in acute myeloid leukemia.
    Hung GY; Chiou TJ; Hsieh YL; Chen PM; Hwang B
    Bone Marrow Transplant; 2002 Jan; 29(1):67-70. PubMed ID: 11840147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Donor cell-derived acute myeloid leukemia developed shortly after allogeneic bone marrow transplantation for MDS overt leukemia].
    Takahashi R; Shimazaki C; Inaba T; Nakagawa M; Yamaoka M
    Rinsho Ketsueki; 2002 Oct; 43(10):963-5. PubMed ID: 12462035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predominant 45,X,--Y karyotype in donor cells after allogeneic BMT: cytogenetic and molecular analysis.
    Abeliovich D; Yehuda O; Nagler A; Lerer I; Ben-Neriah S; Amar A; Or R
    Cancer Genet Cytogenet; 1996 Jan; 86(1):1-7. PubMed ID: 8616777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of a new human acute myelocytic leukemia cell line SH-2 with a loss of Y chromosome, a derivative chromosome 16 resulting from an unbalanced translocation between chromosomes 16 and 17, monosomy 17, trisomy 19, and p53 alteration.
    Qiu H; Xue Y; Zhang J; Pan J; Dai H; Wu Y; Wang Y; Chen S; Wu D
    Exp Hematol; 2008 Nov; 36(11):1487-95. PubMed ID: 18715689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cryptic three-way translocation involving chromosomes 8, 14, and 21 in a case of acute myeloid leukemia subtype M1.
    Lau LC; Koh LP; Lim TH; Loo LE; Tien SL
    Cancer Genet Cytogenet; 2005 Nov; 163(1):86-90. PubMed ID: 16271963
    [No Abstract]   [Full Text] [Related]  

  • 13. Transplantation of bone marrow with constitutional chromosomal anomalies. Cytogenetic studies and clinical implications.
    Becher R; Mahmoud HK; Schaefer UW; Schmidt CG
    Blut; 1986 Oct; 53(4):341-6. PubMed ID: 3530353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matched unrelated donor marrow transplantation in patients with advanced acute leukemia.
    Greinix HT; Reiter E; Schulenburg A; Keil F; Lechner K; Fischer G; Rosenmayr A; Leitner G; Kalhs P
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S53-6. PubMed ID: 9916636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor cell-derived acute lymphocytic leukemia after allogeneic stem cell transplantation for multiple myeloma.
    Igarashi N; Chou T; Hirose T; Imai Y; Ishiguro T; Nemoto K
    Int J Hematol; 2009 Oct; 90(3):378-382. PubMed ID: 19693451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of donor cell derived acute myelogenous leukaemia in a patient transplanted for chronic myelogenous leukaemia using fluorescence in situ hybridization.
    Lowsky R; Fyles G; Minden M; Lipton J; Meharchand J; Tejpar I; Zipursky A; Messner H
    Br J Haematol; 1996 Apr; 93(1):163-5. PubMed ID: 8611454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
    Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocation (7;9)(q22;q34) in therapy-related myelodysplastic syndrome after allogeneic bone marrow transplantation for acute myeloblastic leukemia.
    Yamamoto K; Yakushijin K; Kawamori Y; Minagawa K; Katayama Y; Matsui T
    Cancer Genet Cytogenet; 2007 Jul; 176(1):61-6. PubMed ID: 17574966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation.
    Spinelli O; Giussani U; Borleri G; Lazzari M; Michelato A; Dotti G; Barbui T; Rambaldi A
    Haematologica; 2000 Nov; 85(11):1153-7. PubMed ID: 11064467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation of the NPM1 gene contributes to the development of donor cell-derived acute myeloid leukemia after unrelated cord blood transplantation for acute lymphoblastic leukemia.
    Rodríguez-Macías G; Martínez-Laperche C; Gayoso J; Noriega V; Serrano D; Balsalobre P; Muñoz-Martínez C; Díez-Martín JL; Buño I
    Hum Pathol; 2013 Aug; 44(8):1696-9. PubMed ID: 23465275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.